7 April 2022

Juvenile Arthritis Research Rheumatoid Arthritis

A real shot in the hip for OA

17 March 2022

Ankylosing Spondylitis Biologics Pharmacy Guild of Australia

Mavrilimumab opens up GCA promise

17 March 2022

Biologics COVID-19 Reactive Arthritis

A silver lining to sulfasalazine’s covid fear

10 March 2022

Ankylosing Spondylitis Gout Juvenile Arthritis Pharmacy Guild of Australia Ross River Virus

Promising findings on steroid-sparing options for PMR and GCA

10 March 2022

Ankylosing Spondylitis osteomyelitis Scleroderma

The needle moves on adding more to MTX in PsA

3 March 2022

COVID-19 osteomyelitis PBS

Covid antiviral’s MTX block

24 February 2022

Ankylosing Spondylitis Biologics Polymyalgia Rheumatica Rheumatoid Arthritis Spondyloarthritis

Why men won’t take allopurinol

24 February 2022

Pain Rheumatoid Arthritis

Antidepressant turns volume down on knee OA in trial

17 February 2022

Biologics osteomyelitis Spondyloarthritis

Rates and predictors of MTX side effects

27 January 2022

Gout Research Spondyloarthritis

Real-world data on JAKi and CV outcomes

22 December 2021

COVID-19 Gout

Rheumatology Republic Year in Review

16 December 2021

Gout Spondyloarthritis

JAKi: To cycle or switch?

9 December 2021

Biologics Scleroderma

Promising findings for PsA treatments

18 November 2021

Tofacitinib safety study – more data released

11 November 2021

ACR clinical year in review

8 November 2021

Diet

Vitamin D and omega-3 supplements reduce risk of autoimmune disease